KYTH

Recapping My Most Atrocious Stock Picks of 2015

By John Divine, InvestorPlace Assistant Editor Dec 24, 2015

I look back on my 2015 losers, hopefully learning from my lessons and entering 2016 as a better investor. A painful but necessary examination.

By Ethan Roberts, InvestorPlace Contributor Jun 17, 2015

Fed watch gripped the markets today, but Tripadvisor, Kythera Biopharmaceuticals and Qihoo were all higher for reasons of their own.

By James Brumley, InvestorPlace Feature Writer Jun 17, 2015

Owners of AGN stock have to be wondering of the Kythera deal also marks the spot where their luck finally runs out.

By William White, InvestorPlace Writer Apr 30, 2015

Kythera Biopharmaceuticals Inc's Kybella, which can reduce a person's double chin with a shot, has been approved by the FDA.

By John Divine, InvestorPlace Assistant Editor Mar 9, 2015

Don't let high-flying biotech Kythera Biopharmaceuticals Inc (KYTH) tempt you; it's primed for a gnarly selloff.